KRONOS BIO INC. - COM

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

07 3 2024 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting

05 3 2024 15:44:11 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

27 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement

25 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate

18 12 2023 15:06:03 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

04 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference

27 11 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results

13 11 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study

02 11 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting

02 11 2023 11:00:00 提供 Nasdaq GlobeNewswire

Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting

27 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC

13 10 2023 11:30:00 提供 Nasdaq GlobeNewswire

Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13

04 10 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development

17 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results

08 8 2023 15:05:03 提供 Nasdaq GlobeNewswire

Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance

06 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Participation in Upcoming Investor Conferences

01 6 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results

10 5 2023 15:05:02 提供 Nasdaq GlobeNewswire

Kronos Bio Appoints Roger Dansey, M.D., to Board of Directors

24 4 2023 15:05:00 提供 Nasdaq GlobeNewswire

Kronos Bio Announces Changes to Board of Directors

11 4 2023 15:05:00 提供 Nasdaq GlobeNewswire